This finding suggests that inhibiting mTORC1 signaling and nucleotide synthesis may be a potential strategy targeting SIRT3 to inhibit tumor growth (Gonzalez Herrera et al., 2018). The gene discussed is SIRT3; the disease is neoplasm.